MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00216-026-06338-z

Медицинская библиотека · Analytical and bioanalytical chemistry · 2026

Development of a hypersensitive digital ELISA system for hepatitis B core antigen.

Nakaya Yuki, Hasegawa Takema, Hoshi Yuji, Onomura Daichi, Yamagata Tomoko, Okamoto Hiroaki, Murata Kazumoto, Kato Megumi

СтатьяПеревод в очереди

Аннотация

Chronic hepatitis B (CHB) is a global health threat caused by the hepatitis B virus (HBV). Nucleos(t)ide analogs (NUCs) are the standard treatment for CHB patients with HBV replication. However, NUCs cannot eliminate covalently closed circular DNA (cccDNA), the template for HBV replication, from the nuclei of hepatocytes; hence, patients with CHB need life-long treatment with NUCs because HBV relapses easily upon cessation of NUCs because of the residual cccDNA. However, NUCs can be terminated by accurately monitoring the activity of the cccDNA. Despite the recent development of highly sensitive detection systems for HBV biomarkers, the detection accuracy remains poor, especially at lower concentrations. Therefore, it is desirable to develop more sensitive and reliable biomarkers that have a good correlation with cccDNA, even at lower concentrations. In this study, we developed a digital enzyme-linked immunosorbent assay (ELISA) system for detecting hepatitis B core antigen (HBcAg) using a pair of monoclonal antibodies. The digital ELISA system successfully detected 2.9 pg/mL, which can be converted to 58 aM HBcAg, and the sensitivity was approximately 1000 times higher than that of conventional ELISA. Furthermore, the influence of plasma and serum matrices on the sensitivity can be ignored if the concentrations of the matrices are 1% or less. In addition, the antibody-blocking assay indicated that the digital ELISA system reacted specifically with HBcAg, even in the presence of serum or plasma. Collectively, our highly sensitive digital ELISA system for detecting HBcAg is a potentially new approach for evaluating therapeutic strategies for CHB.

Для цитирования: Nakaya Yuki, Hasegawa Takema, Hoshi Yuji, Onomura Daichi, Yamagata Tomoko, Okamoto Hiroaki, Murata Kazumoto, Kato Megumi. Development of a hypersensitive digital ELISA system for hepatitis B core antigen.. Analytical and bioanalytical chemistry. 2026. DOI: 10.1007/s00216-026-06338-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.